title: The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.
abstract: The 8p11 myeloproliferative syndrome (EMS), also called stem cell leukemia/lymphoma (SCLL), is a relatively rare condition characterized in its typical form by the occurrence, either simultaneously or sequentially, of a bcr/abl-negative myeloproliferative disorder and a lymphoma, usually a precursor T lymphoblastic lymphoma. The disease most often terminates in acute myeloid leukemia which is resistant to conventional chemotherapy. The defining cytogenetic abnormality, a translocation at the 8p11 locus, always involves the fibroblast growth factor 1 (FGFR1) gene. To date, eight partner genes have been identified in association with FGFR1 rearrangements. The most frequent FGFR1 translocation partner is the zinc finger gene ZNF198 located at 13q11. The t(8;13)(p11;q11) disrupts intron 8 of the FGFR1 gene and fuses proline-rich and zinc finger domains of the ZNF198 gene with the cytoplasmic tyrosine kinase domain of FGFR1. Oligomerization of the fusion protein occurs, with subsequent activation of downstream signal transduction pathways, culminating in neoplastic cell transformation. This review describes the historical development of the EMS/SCLL and outlines its cytogenetic abnormalities and molecular mechanisms with an illustrative case.
authors.affiliation: Department of Pathology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. goradiaa@uphs.upenn.edu
authors.forename: Ami
authors.initials: A
authors.lastname: Goradia
authors.forename: Michael
authors.initials: M
authors.lastname: Bayerl
authors.forename: Dennis
authors.initials: D
authors.lastname: Cornfield
references.citation: Br J Haematol. 1994 Apr;86(4):879-80
references.pmid: 7918089
references.citation: Blood. 2004 Jan 1;103(1):309-12
references.pmid: 12969958
references.citation: Cancer Genet Cytogenet. 1993 Jan;65(1):71-3
references.pmid: 8431919
references.citation: Cancer Genet Cytogenet. 2007 Mar;173(2):154-8
references.pmid: 17321332
references.citation: Int J Dev Biol. 2002;46(4):393-400
references.pmid: 12141425
references.citation: Cancer Cell. 2004 Mar;5(3):287-98
references.pmid: 15050920
references.citation: Br J Haematol. 2003 Apr;121(2):312-4
references.pmid: 12694254
references.citation: Genes Chromosomes Cancer. 1998 Feb;21(2):160-5
references.pmid: 9491328
references.citation: Br J Haematol. 2000 Nov;111(2):647-9
references.pmid: 11122115
references.citation: J Biol Chem. 1999 Sep 17;274(38):26922-30
references.pmid: 10480903
references.citation: Blood. 2001 Dec 15;98(13):3778-83
references.pmid: 11739186
references.citation: Neoplasia. 1999 Oct;1(4):349-55
references.pmid: 10935490
references.citation: Blood. 1997 Oct 15;90(8):3136-41
references.pmid: 9376595
references.citation: Acta Haematol. 2002;107(2):98-100
references.pmid: 11919390
references.citation: Am J Surg Pathol. 1992 Mar;16(3):236-45
references.pmid: 1599015
references.citation: Genes Chromosomes Cancer. 2004 May;40(1):78-83
references.pmid: 15034873
references.citation: Leukemia. 1998 Jun;12(6):999-1000
references.pmid: 9639434
references.citation: Blood. 1996 Feb 15;87(4):1658-9
references.pmid: 8608264
references.citation: Genes Chromosomes Cancer. 2001 Dec;32(4):302-10
references.pmid: 11746971
references.citation: Int J Hematol. 1999 Dec;70(4):278-82
references.pmid: 10643154
references.citation: Mol Cell Biol. 2001 Dec;21(23):8129-42
references.pmid: 11689702
references.citation: Blood. 2003 Jan 1;101(1):286-8
references.pmid: 12393597
references.citation: Eur J Haematol. 2006 Oct;77(4):349-54
references.pmid: 16879608
references.citation: Leuk Res. 2008 Jan;32(1):198-9
references.pmid: 17555813
references.citation: Nat Genet. 1998 Jan;18(1):84-7
references.pmid: 9425908
references.citation: Leukemia. 2002 Jul;16(7):1207-12
references.pmid: 12094244
references.citation: Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14479-84
references.pmid: 15448205
references.citation: Blood. 1995 Apr 15;85(8):2025-37
references.pmid: 7718875
references.citation: J Biol Chem. 2004 Feb 20;279(8):6666-73
references.pmid: 14660670
references.citation: Oncogene. 1998 Feb 19;16(7):945-9
references.pmid: 9484786
references.citation: Genes Chromosomes Cancer. 2007 Jul;46(7):635-43
references.pmid: 17394134
references.citation: Blood. 1998 Aug 15;92(4):1456-8
references.pmid: 9694738
references.citation: Acta Haematol. 1992;88(4):201-3
references.pmid: 1292310
references.citation: Blood. 2000 Jul 15;96(2):699-704
references.pmid: 10887137
references.citation: J Clin Oncol. 2000 Feb;18(3):547-61
references.pmid: 10653870
references.citation: Acta Haematol. 2002;107(2):95-7
references.pmid: 11919389
references.citation: Blood. 1997 Oct 15;90(8):3130-5
references.pmid: 9376594
references.citation: Cancer Genet Cytogenet. 1983 Aug;9(4):391-4
references.pmid: 6575862
references.citation: Blood. 1995 Apr 1;85(7):1881-7
references.pmid: 7661940
references.citation: Leukemia. 1995 Oct;9(10):1628-30
references.pmid: 7564500
references.citation: Genes Chromosomes Cancer. 2001 Oct;32(2):155-63
references.pmid: 11550283
references.citation: Leukemia. 2005 Jun;19(6):1005-9
references.pmid: 15800673
references.citation: Genes Chromosomes Cancer. 2005 Mar;42(3):320-5
references.pmid: 15609342
references.citation: Blood. 1999 Feb 15;93(4):1381-9
references.pmid: 9949182
references.citation: Exp Cell Res. 2006 Nov 15;312(19):3739-51
references.pmid: 17027752
references.citation: Blood. 2000 Mar 1;95(5):1788-96
references.pmid: 10688839
references.citation: Br J Haematol. 1994 Apr;86(4):876-8
references.pmid: 7918088